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ROLE OF TRANSCRIPTION FACTORS, RBPA AND SIGF, IN THE 
MYCOBACTERIUM TUBERCULOSIS 
 
STEVEN SCOTT POPE II 
 
ABSTRACT 
 
 The mechanism of prokaryotic transcription has been characterized 
primarily in the classic system, Escherichia coli, and cannot be confidently 
extended to include other prokaryotic species, such as those of the 
Actinobacteria phylum. Actinobacteria represents a diverse group of Gram-
positive species that range from soil dwellers to obligate pathogens, such as 
Mycobacterium tuberculosis (Tb). These species encode RNA polymerase 
(RNAP) binding proteins that are not present in model organisms, and therefore 
present a unique lens through which the basic mechanism of transcription can be 
further explored outside of model systems. In addition, these mechanisms of 
transcriptional regulation can be studied in the context of M. Tuberculosis 
pathogenesis. The model we use for tuberculosis is Mycobacterium Smegmatis, 
a homologue, which has a faster doubling time and is only Biosafety level 1. 
Within Actinobacteria, notable conserved RNAP binding proteins include 
RNA polymerase binding protein A (RbpA) and CarD. RbpA is specific to 
Actinobacteria, binding the β subunit of RNAP and primary σ factors. CarD binds 
to the β subunit and associates with DNA. Both proteins are upregulated upon 
exposure to stress, and have implications in the initiation of rRNA transcription. 
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Each is proposed to stimulate the formation of transcriptionally competent RNAP-
holoenzyme open promoter complexes, and CarD is thought to act as a global 
transcriptional regulator. RbpA and CarD are believed to be essential in M. 
Tuberculosis and M. Smegmatis. Recent structural analyses of RbpA and CarD 
suggest the two proteins may share a region of similarity that could compete for 
binding to the β subunit, and brings into question whether the two proteins are 
capable of coordinately modulating transcription or antagonize each other’s 
activity. This was investigated through purification of CarD and RbpA and in vitro 
studies performed with [α-32P] Uridine triphosphate used to measure the level of 
transcription. These experiments led to the conclusion that RbpA and CarD are 
able to associate with the same RNAP and have an additive stabilizing action on 
the polymerase. Whether or not RbpA is an essential protein was also 
investigated genetically, and by using a Tetracycline on/off system.  
Sigma factors play an important role in transcription due to their ability to 
recognize promoter regions and initiate transcription. One connection that we 
have preliminary data for, through DNA pull downs, is that sigF binds rRNA 
promoters, and CarD and RbpA are both studied in the context of rRNA 
transcription. Therefore sigF is another factor that could be regulating rRNA 
transcription, possibly during stress. SigF is also the sigma factor that responds 
to oxidative stress, and CarD is involved in oxidative stress. Sigma F is a 
member of a family of 13 different sigma factors that are preset in M. 
Tuberculosis. There are two different types of sigma factors: primary, which are 
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essential for normal growth, and alternative, which are typically expressed during 
differing environmental conditions. Sigma F has been shown to be upregulated 
during oxidative stress, which is why it was of particular interest to us. To 
investigate the roles of sig F, we exposed sig F deletion mutants and wild type 
strains to oxidative stress and measured ribosomal RNA production by reverse 
transcription quantitative real time PCR. It was concluded that sigF is a probable 
suppressor of rRNA when exposed to oxidative stress. 
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INTRODUCTION 
 
 
Tuberculosis (Tb) is a disease that affects millions of people worldwide 
each year and thus is a great research concern. Tuberculosis is caused by the 
Mycobacterium Tuberculosis bacteria and usually attacks the lungs, although it 
can attack other parts of the body. Once inside the body, the mycobacterium is 
flagged as foreign and ingested by macrophages. Macrophages try and eliminate 
the pathogen by using oxidative reagents, but tuberculosis has become tolerant 
to these methods and eventually the macrophage will be killed by the 
mycobacterium (Houben Et al., 2006). Tuberculosis can be highly contagious 
and is spread through the air by the coughing or sneezing of infected persons. If 
the disease is left untreated it can be deadly, but with treatment the survival rates 
can be as high as 85% (WHO 2015). Normal symptoms of Tuberculosis are 
unrestful coughing, coughing up blood, chest pain, trouble breathing, fatigue, 
weight loss, and night sweats (Bennett 2010). There are many ways a person 
can be tested for Tuberculosis including a chest X-Ray, a blood test, and a skin 
test (Escalante 2009). These practices are all readily available in the developed 
world but unfortunately less available in the developing world where they are 
needed most.  
Tuberculosis is so prevalent in developing countries because of the large 
number of people with compromised immune systems due to malnutrition, 
HIV/AIDS, or other compromising factors. In 2013 the World Health Organization 
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estimated 1.5 million deaths from tuberculosis and 9.0 million new cases (WHO 
2015). The burden of tuberculosis is placed on developing countries with 85% of 
all tuberculosis cases occurring within Asian and African countries (WHO 2015). 
The Tb problem is further complicated by the fact that Tb often becomes 
resistant to drugs in lower income areas due to lack of access and adherence to 
appropriate drugs.  
 
 
  Figure 1. Estimated Tb incidence: top-ten countries, 2012. The 
problem can be seen in a range of countries and is most prevalent in India but 
has a much higher incidence in Sub-Saharan African countries. (Figure taken 
from WHO Global Tuberculosis report 2015). 
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 Tb can manifest itself in two possible ways, active Tb and latent Tb. A 
person who has Tb and is sick is considered to have active Tb. On the other 
hand, a person can have Tb but the body’s defenses are keeping the person 
healthy and this person is said to have latent Tb. Tb is most often passed 
between people by close contact or close living quarters. This is part of the 
reason it can be so dangerous in a compact community with low access to 
healthcare. Within these vulnerable populations many people have alternative 
factors that can cause Tb to progress into its disease state. One of the most 
prevalent and dangerous factors is being HIV-Positive. There were 1.5 million 
death in 2013, and 360,000 of them were due to the patient being HIV-positive 
(WHO 2015). The HIV-positive cases of Tb are highly concentrated in the African 
region with four of every five cases occurring in that region (WHO 2015). One of 
the most important tools in the survival of Tb patients is HIV testing as this 
reveals crucial information that is key to the patients’ survival. 
 Another very serious factor that can influence the treatment of a Tb patient 
is whether or not the infecting bacterium has developed a drug resistance to 
antibiotics. Multidrug resistant tuberculosis is resistant to two of the most widely 
used anti-tuberculosis drugs, Isoniazid and Rifampicin (Dalton Et al, 2012). 
Multidrug resistant tuberculosis develops when the normal dose of antibiotics is 
interrupted. This happens because there is not enough of the antibiotic in the 
body to kill 100% of the bacteria leading to the bacteria developing a resistance. 
This interruption can be caused by a lack of supply, misinformation, a 
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displacement, or other reasons. Tuberculosis becomes resistant to these first-line 
drugs by altering the bacteria cell wall to block drug entrance, using enzymes 
that modify or inactivate, or mutating the genome which makes the bacterium 
resistant (Louw Et al., 2009).  Furthermore, a resistance to the injectable second 
line of tuberculosis drugs can complicate matters even more. The success rate of 
treatment with rifampicin and isoniazid in non-drug resistant Tb is generally 85% 
or higher. The success rate of treating multidrug resistant strains is much lower 
and treatment lengths can be doubled due to less successful treatments (WHO 
2015). Antibiotics are currently the most successful treatments against Tb due to 
the lack of a vaccine. The existence of Multidrug resistant strains brings the need 
for new first line antibiotics that can help tilt the war on Tb in our favor. 
 The current drugs, Rifampicin and Isoniazid, function differently but are 
both effective in Tb treatment. Rifampicin is a RNA synthesis inhibitor which 
binds to a site on the RNA polymerase that is adjacent to the active site (Calvori 
Et al., 1965). This binding causes an inhibition of RNA synthesis and cripples the 
bacteria. Unfortunately resistance to Rifampicin occurs rapidly which is why it 
must be given in combination with other drugs (Feklistov Et al., 2008). On the 
other hand, Isoniazid is a prodrug, a drug that is inactive, that is activated by 
catalase-peroxidase which is upregulated in response to oxidative stress (Suarez 
Et al., 2009). Once activated, the drug blocks the synthesis of fatty acids in the 
cell which includes the synthesis of mycolic acid. Mycolic acid is required for cell 
wall synthesis, so its blockage stunts bacterial growth.  
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Tb has become such a successful pathogen because of its ability to resist 
stress while invading the host. Much of this stress resistance is dependent on 
transcription, and therefore transcription factors are often targets for 
pharmaceutical interventions because they can be essential in a functioning 
mycobacterium (Raman Et al., 2004). If these transcription factors are discovered 
and the structure, mechanism, and interacting partners can be determined it can 
prove to be an effective site for intervention.  
Transcription of a gene is initiated by the binding of a promoter element to 
DNA and the formation a closed complex. Isomerization then occurs and the 
DNA unwinds and is exposed, which is referred to as an open complex. RbpA is 
thought to play a key role in the stabilization of this process. This is why RbpA 
has become such an interesting protein that has been identified as an essential 
gene in Tb. RbpA is a highly conserved gene in actinobacteria that was first 
discovered in Streptomyces coelicolor where it was shown to stimulate 
transcription in vitro (Newell et al., 2006). RbpA interacts with a RNA polymerase 
and creates a protein-protein interaction. RbpA is thought to associate with the 
Beta and Sigma subunits of the holoenzyme and initiate the forming of an open 
complex (Tabib-Salazar et al., 2013).  
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Figure 2. Model of RNAP & RbpA Interaction. The sigma and beta units of a holoenzyme are represented in this 
model and with the addition of promoter DNA and RbpA, represented in red, an open complex can be formed to 
initiate transcription (Figure Taken from Hu et al., 2014).
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 Sigma subunits are responsible for recognizing the -10 and -35 promoter 
regions which allow the holoenzyme to bind to the promoter DNA and form a 
closed complex. With the help of RbpA these closed complexes can stabilize in 
an open complex configuration, which exposes single stranded DNA for 
transcription to occur. As can be seen from Figure 2, RbpA is essential in forming 
the open complex to initiate transcription. CarD is thought to have a similar 
function and has been proven to interact with RNAP and stabilize the 
holoenzyme which leads to increased transcription (Garner et al., 2014).  
 SigF is an alternative sigma factor that is often associated with stress. 
SigF has not been labeled as essential because deletion mutants do not have 
decreased growth in broth culture or human macrophages (Gebhard et al., 
2008). However, sigF has been proven to affect hydrogen peroxide sensitivity 
and therefore oxidative stress sensitivity (Provvedi et al. 2008). Hydrogen 
peroxide or oxidative species are often produced by the host in response to an 
invading pathogen which subjects the pathogen to oxidative stress as a defense 
mechanism. Tuberculosis has developed the ability to resist this oxidative stress, 
which is the reason it is a topic of interest.  
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Specific Aims/Objectives 
 
RbpA is an essential transcription factor in Tuberculosis but there is still 
much that can be learned from the exact mechanism by which the protein 
regulates transcription as well as interacting partners and the effect on 
transcription. SigF is already known to be an effector during times of stress which 
is why it is such an interesting research target. Tuberculosis undergoes stress 
while in the human lung so sigF is most likely expressed during infections.  
 
 
The specific aims and objectives of this thesis are as follows. 
 
1. Obtain further evidence as to whether or not RbpA is essential in mycobacterium 
smegmatis. 
2. Determine if CarD and RbpA can associate with the RNAP at the same time.  
3. Determine the extent to which the RNAP-promoter complex is stabilized with 
RbpA and in conjunction with CarD. 
4. Investigate the effect of sigF on transcription in stressful environments. 
 
By investigating these objectives we can better understand transcription in Tb 
and more specifically we can better understand the role of RbpA alone, and in 
conjunction with CarD, and the role of sigF in transcription.  
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METHODS 
Investigation of RbpA essentiality 
Whether or not RbpA is truly essential was researched in two different 
ways – the attempt to create a clean deletion of RbpA from the genome and the 
use of a tetracycline system to deplete the protein and monitor the effects on 
growth. The attempt to create a clean deletion of RbpA was performed by a 
series of cloning techniques and checked by southern blot. Rv2050c is the gene 
that encodes RbpA in the Tb genome and was amplified from the genome using 
PCR. This PCR product was verified to be the correct size by gel electrophoresis 
and extracted from the gel and purified. The purified PCR product was then 
ligated into the pmsg430 vector which is used to insert a gene, RbpA, into the 
attB site. This would allow for the deletion of the endogenous RbpA site by using 
the pDB88 vector.  
By using the pDB88 vector we were able to create regions that flanked the 
endogenous RbpA and use homologous recombination to remove RbpA and 
leave only one copy of RbpA inserted at the attB site. We were able to select for 
the correct product that had successfully deleted the endogenous RbpA. 
Southern blot was used to determine which product was present, the wild type or 
the strain with RbpA at the attB site. Using a radiolabeled probe that contained a 
portion of the flanking region we were able to distinguish which samples were the 
mutants and which samples were wild type. The sample that contained the 
correct deletion was given the name Csm275.  
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Figure 3. Southern Blot of RbpA Mutants and Wild Type M. smegmatis. 
There were 2 correct mutants of the numerous samples tested. These mutants 
contained RbpA and a Kanamycin resistance cassette at the attB site with the 
endogenous RbpA deleted. 
 
 We were then able to perform two transformations with the pDB19 plasmid 
through homologous recombination. One transformation contained the pDB19 
plasmid with RbpA, which had previously been transformed in, and one 
transformation contained empty pDB19. With successful transformations this 
would yield one mutant with empty pDB19 and one mutant with pDB19 
containing RbpA. With a successful transformation the first mutant with empty 
pDB19 would have lost all copies of RbpA. 
 Another experiment was done to test the effect of losing RbpA by using a 
depleting Tetracycline system. Two new strains were made using Csm275, one 
  11
which contained a Tetracycline-On operator and another which contained a 
Tetracycline-Off operator. These strains were made by using a pre-purified 
vector that had the ability to suppress the gene at the attB site. This vector did 
not insert directly into the same plasmid as RbpA but the operator controlled the 
promoter at the attB site which would allow us to control the expression of RbpA. 
In an ATc-On system the tetracycline protein is only allowed to bind to the 
promoter at the attB site if bound to ATc and in the ATc-Off system the protein is 
only bound to the promoter in the absence of tetracycline. Four cultures were 
prepared – an ATc-On strain with ATc added, an ATc-On strain without ATc 
added, an ATc-Off strain with ATc added, and finally an ATc-Off strain without 
ATc added. These strains represented two depleting strains and two healthy 
strains, one for each of the On/Off systems. With these four cultures we could 
monitor the effect of the depletion of RbpA over the next 48 hours. Samples were 
taken to measure the optical density at a wavelength of 600nm every 3 hours 
during the day, then back diluted to an optical density of 0.2 the next morning. 
The experiment was carried out until 52 hours. At the same time points dilutions 
were plated at concentrations of undiluted, 10, 10, 10, and 10. These 
dilutions were plated to check for survival over the course of the growth curve.  
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CarD and RbpA interaction in vitro 
 
 
 RbpA and CarD are thought to have similar functions, similar structures, 
and possibly compete for the same binding site (Kaur 2013). To investigate the 
interactions between RbpA, CarD, and the RNAP an in vitro assay was used. 
The core RNAP, sigma factors, RbpA, and CarD were purified previously. The 
proteins were purified from pETSUMO protein-expressing BL21 E. Coli cells 
using nickel affinity chromatography. In the final reaction the concentrations of 
core, sigma, RbpA, and CarD were 80nM, 320nM, 320nM, and 320nM 
respectively. The core RNAP was first incubated with RbpA/CarD/dialysis buffer, 
or CarD and RbpA together for 10 minutes. The Sigma Factor is then added and 
the reaction is moved to 37ºC for 10 minutes. A combination of 40mM NaCl 
transcription buffer, 50ng of a template DNA, and nucleotide free water is added 
to bring the reaction volume up to 10.25µl. The reaction is then allowed to 
incubate another 10 minutes at 37ºC at which point it is initiated by 2.25µl of a 
nucleotide mix which contains ATP, GTP, CTP, and  [α-32P] UTP. In a single 
round reaction there is a double stranded DNA competitor which competes for 
the holoenzyme and only one round of transcription is allowed to take place. In a 
multi-round reaction there is not a competitor and the reaction is allowed to 
complete multiple rounds of transcription. Both types of assays were performed 
in my research as both were of interest. After the reaction has run for 15 minutes 
it is stopped by a 7M Urea stop buffer and placed on ice. 
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 The reaction is then run on a 5.5% denaturing acrylamide gel and the gel 
is allowed to dry for 1 hour at 80 ºC and placed on a phosphoimaging screen 
which detects radioactive signals. The signal is displayed as bands and we were 
able to quantify the signal of the band and compare the stabilization of the 
RNAP. 
 
SigF regulation of transcription  
 
 SigF was investigated under stressful conditions in order to mimic 
conditions present in vivo. A sigF deletion mutant was cloned in order to 
appropriately study the effects on transcription. To create this mutant, two flanks, 
one on each side of M. smegmatis sigF, were created and cloned into pDB88. As 
with RbpA, the endogenous sigF was then deleted using flanking regions in 
pDB88 and homologous recombination. But unlike RbpA, sigF is not essential so 
it was not necessary to insert at the attB site using pmsg430, and a clean 
deletion could be made. The clean deletion was tested by southern blot and we 
were able to differentiate the wild type from the sigF deletion mutants. The 
sample that contained the correct deletion was given the name Csm278. 
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Figure 4. Southern Blot of ΔsigF Mutants and Wild Type M. smegmatis. 
There were 5 sigF mutants that were recorded after checking by Southern Blot. 
These mutants contained a clean deletion of sigF and had no antibiotic 
resistance.  
 
 With this mutant we were able to conduct experiments which exposed the 
mutant and wild type to oxidative stress and use reverse transcription PCR to 
monitor the exposure to oxidative stress, the ribosomal RNA, and the regulation 
of CarD. In the experiment, six cultures of wild type M. smegmatis, and six 
cultures of the sigF deletion strain were grown to logarithmic phase. 
Mycobacterium initially grow in a logarithmic fashion until they reach a certain 
confluence at which point they plateau and maintain a stable optical density. We 
performed our experiments when the bacterium was in logarithmic phase 
because this is when the most transcription and replication is happening.  
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After the bacterium reached logarithmic phase, three cultures of each 
strain were collected to isolate RNA for reverse transcription PCR. The remaining 
three for each strain were treated with 10nM Hydrogen Peroxide and allowed to 
incubate for 1 hour. After 1 hour these strains were collected to isolate RNA. 
RNA was isolated using Trizol reagent and a chloroform extraction technique. 
After the RNA for each sample was isolated the samples were treated with 
reverse transcriptase to make complementary DNA. With complementary DNA 
the sample could be safely stored and reverse transcription PCR could be 
performed. Real time reverse transcription PCR uses SYBR Green which emits a 
florescent light upon creation of PCR product and intensifies with accumulation of 
the product. 
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RESULTS 
 
 
Investigation of RbpA essentiality 
 
 Whether or not RbpA is essential was investigated by using the strain 
mentioned above which contained RbpA at the attB site with a Kanamycin 
resistance. RbpA was cloned into pDB19 and with this vector containing RbpA 
we were able to replace the Kanamycin resistance with a Zeocin resistance and 
the resulting strain was resistant to Zeocin. Another transformation that was 
attempted was transforming empty pBD19 vector, which would replace the 
Kanamycin resistance and RbpA with a Zeocin Resistance. This transformation 
would remove RbpA from the attB site and leave the strain without a copy of 
RbpA. Both transformations were performed and both transformations were 
plated on Kanamycin and Zeocin. 
 This type of transformation has been used by the Stallings lab previously 
to determine the outcome of a probable essential gene. It is reliable because it is 
a common transformation that should be successful and if unsuccessful then a 
likely mutation occurred or the transformation was not 100% clean. 
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Csm275 + pDB19 RbpA on Zeocin       Csm275 + pDB19 RbpA on Kanamycin 
 
     
 
         Csm275 + pDB19 on Zeocin              Csm275 + pDB19 on Kanamycin 
 
     
Figure 5. Csm275 + pDB19 or pDB19 RbpA on Kanamycin or Zeocin. pDB19 
or pDB19 RbpA was transformed into Csm275 and then plated on either Zeocin 
or Kanamycin and growth was recorded. 
 
 These plates were indicative of RbpA being essential due to the inability of 
the mycobacterium to lose the gene. If RbpA was not essential the 
transformation that contained empty pDB19 would have successfully transformed 
into the strain and left the resulting bacteria without a copy of RbpA. Instead the 
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resulting strain became Zeocin and Kanamycin resistant which meant the 
bacteria had not lost RbpA.  
Another experiment was done to test the growth of different strains when 
RbpA was repressed by an ATc operator. We expected the ATc-On system to 
grow better in the presence of ATc and the ATc-Off system to grow better in the 
absence of ATc. 
 
 
Figure 6. RbpA Depletion Growth Curve. In the growth curve the defect can be 
seen in the ATc-Off + ATc culture and the ATc-On –ATc culture, with the defect 
being more prominent in the ATc-ON –ATc.  
 
 The growth defect present in the two strains that repressed RbpA can be 
seen in the above graph with the defect in ATc-On – ATc being more prominent. 
After a certain period of time the Tetracycline operator can become suppressed 
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because the bacterium needs the gene to survive. This is most likely what 
happens in the ATc-Off + ATc strain. There is an initial growth defect but the 
strain seems to recover near the 50 hour time point. In either example it can be 
seen that there is some sort of defect in both of these strains which is indicative 
of RbpA being an essential gene. Had RbpA not been essential then there would 
not be a growth defect in any strains due to the ability of the bacteria to survive 
without RbpA.  
 This experiment was also replicated by plating the same cultures for 
survival at the same time points the ODs were recorded. The dilutions that 
showed the best difference in colony formation was the 10 dilution after 2 days 
of growth. The colonies were counted and graphed to visualize the survival of 
different strains.  
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Figure 7. ATc On/Off strains plated for survival. A similar trend can again be 
seen on the survival plates with the two non-depleting strains having more 
colonies than the depleting strains. 
 
This is indicative of a growth defect due to the depletion of RbpA in the 
depleting strains. This graph only confirms what was previously seen when the 
optical densities were measured at the same time points. 
 
CarD and RbpA interaction in vitro 
 
 CarD and RbpA were placed in an in vitro assay with RNAP and the 
transcription was measured by radiolabeled [α-32P] UTP. RbpA and CarD were 
first measured with the RNAP separately in a single round assay. These assays 
contained a double stranded DNA competitor which was used to limit the RNAP 
to a single round of transcription. The bands were quantified on a gel which 
showed increasing intensity with increasing levels of transcription.  
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Figure 8. Autoradiographs of transcripts. These bands were seen on a 
denaturing polyacrylamide gel. Bands were quantified and represent stabilized 
RNAP. 
 
 Each experiment yielded a similar gel in which bands were quantified and 
then graphed to visualize the effect of the protein on the RNAP. These bands are 
recording the activity of the AP3 promoter which was the promoter used in these 
particular in vitro assays.  
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Figure 9. Single Round In Vitro Assays. It can be seen from these assays 
CarD is the most efficient at stabilizing the RNAP while RbpA is slightly less 
efficient, but more efficient than the no factor.  
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 Multi Round assays were also performed which did not contain a double 
stranded DNA competitor. For reasons unknown RbpA has a better effect in 
these assays and CarD seems to be less efficient. This effect was also seen in 
the Multi Round assays that were performed with CarD and RbpA together. With 
both CarD and RbpA combined the results showed an additive effect of CarD 
and RbpA with the final result producing more transcription than CarD alone but 
less than RbpA alone.  
 
 
Multi Round In Vitro Assay 
  
 Table 1. Multi Round In Vitro Assay. In the Multi Round assays there 
seemed to be a consistently larger amount of transcript produced when RbpA 
was added and less when CarD was added. 
  
 The final experiments added CarD and RbpA together to observe the 
effects they could have on the same RNAP. This was to test whether they had 
additive effects or whether they compete for the same binding site. It was also to 
test whether they could associate with the same RNAP. These experiment were 
Protein Transcription Normalized to No Factor
No Factor 1
CarD 0.876468796
RbpA 1.484158381
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done with both single and multi-round assays. These assays only measured a 
single time point, 10 minutes, which we determined was an appropriate time 
point that allowed us to distinguish the differences between half-lives of the 
differing proteins and RNAP. 
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Figure 10. Single Round CarD + RbpA Assays. In the Single Round assays 
that combined CarD and RbpA the combination of the proteins tends to stabilize 
the RNAP longer than either protein alone. 
  
 The results of this experiment were not as consistent as we would have 
liked due to much troubleshooting. But we came to the conclusion that CarD and 
RbpA can associate with the same RNAP and have additive effects on the 
stabilization of the RNAP. Both of these proteins had been proved to stabilize 
RNAP in the past but never together. This was very exciting because it showed 
two very similar proteins that have similar functions cooperating with the same 
RNAP instead of competing for a single binding site. This discovery gave us 
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some insight into the action of these proteins in vivo as they are both present and 
likely have some sort of interaction.  
 Multi-Round assays were also performed with both proteins and the 
effect was again additive. In these reactions the stabilization was not at its best 
when both proteins were combined because CarD does not have a strong effect 
in multi-round assays for unknown reasons. But this again proved that CarD and 
RbpA could both interact with the same RNAP at the same time and have an 
additive effect. 
Multi-Round CarD + RbpA Assay 1 
 
Multi-Round CarD + RbpA Assay 2 
 
Multi-Round CarD + RbpA Assay 3 
 
Protein Transcription Normalized to No Factor
No Factor 1
CarD 0.588923079
RbpA 1.009847012
CarD + RbpA 0.77503738
Protein Transcription Normalized to No Factor
No Factor 1
CarD 0.369185205
RbpA 1.513660701
CarD + RbpA 0.497764142
Protein Transcription Normalized to No Factor
No Factor 1
CarD 0.895770116
RbpA 3.624335085
CarD + RbpA 1.152380424
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Table 2. Multi-Round CarD + RbpA Assays. The additive effect of CarD and 
RbpA can be seen in the above tables. The RNAP with RbpA were the most 
stable and the RNAP with CarD were the least stable. When the two were added 
the resulting stability was intermediate.  
 
 Without the double stranded DNA competitor CarD seems less efficient 
and it is unknown whether the multi or single round assay is more likely to 
replicate in vivo conditions. Regardless of which is more indicative of how 
tuberculosis act, the action of CarD and RbpA together can be clearly seen to be 
cooperative. This gives an insight on how these two proteins interact during 
transcription and clearly show that both have an important impact on the 
stabilization of the transcription bubble and the RNAP as well as an impact on 
the amount of transcript made. 
 
 
SigF regulation of transcription  
 
 SigF is another factor that was studied due to its role in stressful 
conditions. The role sigF plays in transcriptional activity was studied by exposing 
M. smegmatis to hydrogen peroxide to emulate oxidative stress. The cells were 
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then prepped and RNA was isolated which could be used in reverse transcription 
PCR to measure gene expression. The genes measured were CarD, KatG, and 
rRNA. KatG is a gene that has been proved to be upregulated during stress 
which is the reason it was tested in this experiment. KatG is a gene that codes 
for the enzyme catalase-peroxidase which assists in the decomposition of 
hydrogen peroxide (LeBlanc Et al., 2006). CarD was monitored due to the 
interest in possible CarD and sigF interactions during oxidative stress. 
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Figure 11. Gene Expression Pre and Post Oxidative Stress. KatG is clearly 
upregulated post oxidative stress which is what is expected. CarD seem to be 
generally unaffected and rRNA could potentially be slightly elevated.  
 
 We were unable to draw definitive conclusions from this experiment due to 
time constraints but further investigation is required. There is a possibility that 
sigF is a repressor of rRNA due to the slight increase in rRNA in the sigF mutant 
compared to the wild type. Reverse transcriptase PCR was used on the same 
samples but amplifying the area in the genome between the 16S and 23S 
ribosomes. This area would be upregulated in the sigF mutant if sigF was indeed 
a repressor of rRNA 
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Figure 12. 16S – 23S region Pre and Post Oxidative Stress The region 
between the 16S and 23S was slightly elevated in the sigF mutant after exposure 
to oxidative stress which is similar to the previous experiment. 
  
 These results are suggestive of sigF being a suppressor of rRNA during 
stressful conditions but the results are not statistically significant and further 
study would be required to investigate the viability of this hypothesis. But since 
both regions of the genome produced similar results it is predictive of sigF being 
a suppressor of rRNA. 
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DISCUSSION 
 
 
 The investigation of transcriptional regulators in Tb is needed because of 
the implications these discoveries can have on the creation of more effective Tb 
drugs. Tb is able to develop resistance to many first line drugs and once that 
resistance is established it can be very difficult to continue a successful treatment 
regimen. Transcriptional regulators have been proven in the past to be effective 
in treating Tb as one of the most successful, Rifampicin, is a first line drug. The 
drawback is that many strains of Tb are now resistant to Rifampicin and other 
drugs, which introduces the need for new and improving drugs. 
 CarD is a protein that is heavily studied in the Stallings Laboratory and 
has been proven to stabilize the RNAP and increase its half-life. RbpA is a new 
protein that is thought to have a similar function and from my experiments it has 
been confirmed that RbpA is essential and that RbpA and CarD can cooperate 
on the same RNAP and have an additive effect. RbpA being essential is an 
important factor because it allows us to realize the impact the protein is having 
on the overall life cycle of the bacterium. If the bacteria is unable to live without 
this protein then it may be a good target due to its essential nature, but it may 
also result in mutations that allow the bacterium to persist. The combination of 
my experiments, previous experiments and attempts to create a RbpA deletion 
mutant from other groups indicate that RbpA is very likely to be essential. The 
inability to lose the gene even though it is being transformed out of a plasmid and 
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the growth defect noted in two strains of the Tetracycline experiment both 
indicate that RbpA is an essential gene.  
 Since RbpA has been identified as essential it is necessary to understand 
how it interacts with the RNAP. The exact mechanism is still not understood but 
the investigation on how it interacts with CarD is intriguing due to their similar 
natures. RbpA has been previously shown to interact with the RNAP and 
stabilize the RNAP to allow for increased transcription (Hu et al., 2014). We 
wanted to reproduce these effects and further the experiment by testing both 
CarD and RbpA together. The effects of CarD and RbpA were both shown to be 
similar in the fact that they stabilized the RNAP but at varying levels of 
effectiveness. When added together in the same assay it became apparent that 
they cooperated on the RNAP instead of competing for a similar binding site as 
previously hypothesized. This did not reveal the mechanism but it did shed light 
on the interactions between the two proteins and proved they were capable 
interacting partners. 
 The in vitro assays were by no means perfect and many days of 
troubleshooting went into reproducing the reported effects of RbpA and CarD. A 
large problem was inconsistency in the effects of the two proteins as can be seen 
in the data. Despite these inconsistencies, the combination of the two proteins 
almost always created a more stable RNAP which led us to conclude with a 
degree of certainty that the proteins were in fact interacting on the same RNAP 
during the same transcription cycle. This is an important fact going forward with 
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RbpA research because it has verified a possible interacting partner during 
transcription. 
 The final experiment that focused on the transcriptional role of sigF hinted 
at sigF being a repressor of rRNA during times of stress. The fact that two 
different regions of the genome that are involved in transcription were both 
slightly upregulated in the sigF mutant could indicate a role of sigF. Further 
investigation would be needed to delve into this theory but it is a starting point 
regarding the role of sigF. Future directions would repeat the experiment and 
expose the wild type and sigF mutant to varying concentrations of hydrogen 
peroxide and visualize the effects on transcription. 
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